- January 31, 2022
Two New Haven Locations Use Yale’s SalivaDirect COVID-19 Test
- January 27, 2022Source: The New Haven Register
New partnership between CT, Yale to expand saliva-based COVID testing at 2 New Haven locations
- November 01, 2021Source: YaleNews
FDA Authorizes Sample Pooling for Yale-developed SalivaDirect COVID Test
- August 26, 2020
Sex Differences in COVID-19 Immune Responses Affect Patient Outcomes
- August 15, 2020Source: YaleNews
Quick and Affordable Saliva-based COVID-19 Test Developed by Yale Scientists Receives FDA Emergency Use Authorization
- June 22, 2020Source: YaleNews
Yale and NBA Partner to Study Efficacy of New COVID-19 Test
Welcome
Our research focuses on the mechanisms driving the observed epidemiological patterns of respiratory infections, particularly pneumococcal disease and RSV. Pneumococcus causes a large burden of disease worldwide, particularly among young children and the elderly.
Major research questions in the lab are related to long-term bacterial evolution, impacts of immunization on carriage and disease in different populations, and seasonal determinants of bacterial disease incidence (including viral co-infections and carriage). These projects utilize both quantitative tools and experimental laboratory studies.
You can learn more about our research and recent publications here.
Primary Investigator
Daniel Weinberger, PhD
Associate Professor of Epidemiology (Microbial Diseases)